Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire

Table 4

Multivariate linear regression analyses of the change in SF-36 measures at follow-up vs. baseline^∗.

Measures	Mean change±SD	Category	Coeff. (95% CI)	P
PF	15.11±23.10
Group		A vs B	13.13 (11.24, 27.02)	<0.0001
Sex		Male vs Female	-12.12 (-19.91, -4.34)	0.003
RP	25.00±41.66
Group		A vs B	43.74 (30.21, 57.28)	<0.0001
Occupation		Employed vs other	-17.31 (-32.09, -2.53)	0.022
GH	4.46±19.52
Group		A vs B	21.42 (15.21, 27.63)	<0.0001
Occupation		Employed vs other	-8.84 (-15.63, -2.06)	0.011

PF = physical functioning, RP = role physical, GH = general health.
^∗In multivariate linear regression analyses of all other measures (not shown), Group was the only statistically significant predictor (p<0.0001 in all analyses).